Indeed, upregulation of HIF-1α expression is observed in multiple cancers, including colon cancer, breast cancer, prostate cancer, chronic myelogenous leukemia, glioblastoma, rhabdomyosarcoma, and leukemia [33–35]. The gene discussed is HIF1A; the disease is prostate carcinoma.